Review of Management and Outcomes in Women with Thrombophilia Risk during Pregnancy at a Single Institution

Pregnancy is a hypercoagulable state associated with an increased risk of venous thromboembolic disease (VTE). We retrospectively studied 38 Caucasian pregnant women with thrombophilia risk and compared their obstetric outcomes with a matched cohort without known thrombophilia risk during the period...

Full description

Saved in:
Bibliographic Details
Published in:ISRN obstetrics and gynecology 2014, Vol.2014, p.381826-6
Main Authors: Khalafallah, Alhossain A., Ibraheem, Abdul-Rauf O., Teo, Qiong Yue, AlBarzan, Abdul-Majeed, Parameswaran, Ramanathan, Hooper, Emily, Pavlov, Toly, Dennis, Amanda E., Hannan, Terry
Format: Article
Language:English
Subjects:
Anticoagulants
Clinical Study
Health risk assessment
Mortality
Mutation
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2896-efcac35b20ebdc99dbcc62e948208c803875bdc8917c200eda3d93926dd52a1f3
cites cdi_FETCH-LOGICAL-c2896-efcac35b20ebdc99dbcc62e948208c803875bdc8917c200eda3d93926dd52a1f3
container_end_page 6
container_issue
container_start_page 381826
container_title ISRN obstetrics and gynecology
container_volume 2014
creator Khalafallah, Alhossain A.
Ibraheem, Abdul-Rauf O.
Teo, Qiong Yue
AlBarzan, Abdul-Majeed
Parameswaran, Ramanathan
Hooper, Emily
Pavlov, Toly
Dennis, Amanda E.
Hannan, Terry
description Pregnancy is a hypercoagulable state associated with an increased risk of venous thromboembolic disease (VTE). We retrospectively studied 38 Caucasian pregnant women with thrombophilia risk and compared their obstetric outcomes with a matched cohort without known thrombophilia risk during the period between January 2007 and December 2010. There were (2) cases with factor V Leiden, (6) prothrombin gene mutation, (1) antithrombin III deficiency, (2) protein C deficiency, (3) protein S deficiency, (10) MTHFR mutation, (7) anti-cardiolipin antibodies, and (1) lupus anticoagulant. Patients without thrombophilia who presented with recurrent unprovoked VTE were considered as high risk (6 cases). Most patients received anticoagulation (34/38) with aspirin only (6), enoxaparin (27), and warfarin (1). Twenty-six out of thirty-eight pregnant women (68.4%) with an increased risk of thrombophilia experienced one or more obstetric complications defined as hypertension, preeclampsia, placenta abruptio, VTE, and oligohydramnios, compared with 15 out of 40 (37.5%) pregnant women in the control group (OR 3.6; 95% CI 1.42, 9.21, P
doi_str_mv 10.1155/2014/381826
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3945432</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1512556070</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2896-efcac35b20ebdc99dbcc62e948208c803875bdc8917c200eda3d93926dd52a1f3</originalsourceid><addsrcrecordid>eNp9kd1rFTEQxYMotrR98l0Cvohy23xscpMXQYofhUqlVnwM2WT2btrd5Jrs9tL_3pRbL9qHzssMc34cZjgIvaLkmFIhThihzQlXVDH5DO0zosmiqfV8N3O5h45KuSa1Gs2WSrxEe6yRmldtH91cwm2ADU4d_majXcEIccI2enwxTy6NUHCI-FcdIt6EqcdXfU5jm9Z9GILFl6HcYD_nEFf4e4ZVtNHdYVsd8I-6GwCfxTKFaZ5CiofoRWeHAkcP_QD9_Pzp6vTr4vziy9npx_OFY0rLBXTOOi5aRqD1TmvfOicZ6EYxopwiXC1FFZSmS8cIAW-511wz6b1glnb8AH3Y-q7ndgTv6kfZDmadw2jznUk2mP-VGHqzSreG60Y0nFWDtw8GOf2eoUxmDMXBMNgIaS6GCsqEkGRJKvrmEXqd5hzre5WSNRhGJK3U-y3lciolQ7c7hhJzn6O5z9Fsc6z063_v37F_U6vAuy3Qh-jtJjzp9gcMMaXB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1563812061</pqid></control><display><type>article</type><title>Review of Management and Outcomes in Women with Thrombophilia Risk during Pregnancy at a Single Institution</title><source>PubMed Central(OpenAccess)</source><creator>Khalafallah, Alhossain A. ; Ibraheem, Abdul-Rauf O. ; Teo, Qiong Yue ; AlBarzan, Abdul-Majeed ; Parameswaran, Ramanathan ; Hooper, Emily ; Pavlov, Toly ; Dennis, Amanda E. ; Hannan, Terry</creator><contributor>Pacora, P. ; Kühnert, M. ; Palomba, S.</contributor><creatorcontrib>Khalafallah, Alhossain A. ; Ibraheem, Abdul-Rauf O. ; Teo, Qiong Yue ; AlBarzan, Abdul-Majeed ; Parameswaran, Ramanathan ; Hooper, Emily ; Pavlov, Toly ; Dennis, Amanda E. ; Hannan, Terry ; Pacora, P. ; Kühnert, M. ; Palomba, S.</creatorcontrib><description>Pregnancy is a hypercoagulable state associated with an increased risk of venous thromboembolic disease (VTE). We retrospectively studied 38 Caucasian pregnant women with thrombophilia risk and compared their obstetric outcomes with a matched cohort without known thrombophilia risk during the period between January 2007 and December 2010. There were (2) cases with factor V Leiden, (6) prothrombin gene mutation, (1) antithrombin III deficiency, (2) protein C deficiency, (3) protein S deficiency, (10) MTHFR mutation, (7) anti-cardiolipin antibodies, and (1) lupus anticoagulant. Patients without thrombophilia who presented with recurrent unprovoked VTE were considered as high risk (6 cases). Most patients received anticoagulation (34/38) with aspirin only (6), enoxaparin (27), and warfarin (1). Twenty-six out of thirty-eight pregnant women (68.4%) with an increased risk of thrombophilia experienced one or more obstetric complications defined as hypertension, preeclampsia, placenta abruptio, VTE, and oligohydramnios, compared with 15 out of 40 (37.5%) pregnant women in the control group (OR 3.6; 95% CI 1.42, 9.21, P&lt;0.001). The incidence of obstetric complications was significantly higher in the thrombophilia group compared to the controls. However, these complications were the lowest among patients who received full-dose anticoagulation. Our study suggests that strict application of anticoagulation therapy for thrombophilia of pregnancy is associated with an improved pregnancy outcome. The study was registered in the Australian and New Zealand Clinical Trials Registry under ACTRN12612001094864.</description><identifier>ISSN: 2090-4436</identifier><identifier>ISSN: 2090-4444</identifier><identifier>EISSN: 2090-4444</identifier><identifier>DOI: 10.1155/2014/381826</identifier><identifier>PMID: 24693443</identifier><language>eng</language><publisher>United States: Hindawi Publishing Corporation</publisher><subject>Anticoagulants ; Clinical Study ; Health risk assessment ; Mortality ; Mutation ; Womens health</subject><ispartof>ISRN obstetrics and gynecology, 2014, Vol.2014, p.381826-6</ispartof><rights>Copyright © 2014 Alhossain A. Khalafallah et al.</rights><rights>Copyright © 2014 Alhossain A. Khalafallah et al. Alhossain A. Khalafallah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2014 Alhossain A. Khalafallah et al. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2896-efcac35b20ebdc99dbcc62e948208c803875bdc8917c200eda3d93926dd52a1f3</citedby><cites>FETCH-LOGICAL-c2896-efcac35b20ebdc99dbcc62e948208c803875bdc8917c200eda3d93926dd52a1f3</cites><orcidid>0000-0002-0097-5241 ; 0000-0002-1580-3135</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945432/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945432/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4009,27902,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24693443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Pacora, P.</contributor><contributor>Kühnert, M.</contributor><contributor>Palomba, S.</contributor><creatorcontrib>Khalafallah, Alhossain A.</creatorcontrib><creatorcontrib>Ibraheem, Abdul-Rauf O.</creatorcontrib><creatorcontrib>Teo, Qiong Yue</creatorcontrib><creatorcontrib>AlBarzan, Abdul-Majeed</creatorcontrib><creatorcontrib>Parameswaran, Ramanathan</creatorcontrib><creatorcontrib>Hooper, Emily</creatorcontrib><creatorcontrib>Pavlov, Toly</creatorcontrib><creatorcontrib>Dennis, Amanda E.</creatorcontrib><creatorcontrib>Hannan, Terry</creatorcontrib><title>Review of Management and Outcomes in Women with Thrombophilia Risk during Pregnancy at a Single Institution</title><title>ISRN obstetrics and gynecology</title><addtitle>ISRN Obstet Gynecol</addtitle><description>Pregnancy is a hypercoagulable state associated with an increased risk of venous thromboembolic disease (VTE). We retrospectively studied 38 Caucasian pregnant women with thrombophilia risk and compared their obstetric outcomes with a matched cohort without known thrombophilia risk during the period between January 2007 and December 2010. There were (2) cases with factor V Leiden, (6) prothrombin gene mutation, (1) antithrombin III deficiency, (2) protein C deficiency, (3) protein S deficiency, (10) MTHFR mutation, (7) anti-cardiolipin antibodies, and (1) lupus anticoagulant. Patients without thrombophilia who presented with recurrent unprovoked VTE were considered as high risk (6 cases). Most patients received anticoagulation (34/38) with aspirin only (6), enoxaparin (27), and warfarin (1). Twenty-six out of thirty-eight pregnant women (68.4%) with an increased risk of thrombophilia experienced one or more obstetric complications defined as hypertension, preeclampsia, placenta abruptio, VTE, and oligohydramnios, compared with 15 out of 40 (37.5%) pregnant women in the control group (OR 3.6; 95% CI 1.42, 9.21, P&lt;0.001). The incidence of obstetric complications was significantly higher in the thrombophilia group compared to the controls. However, these complications were the lowest among patients who received full-dose anticoagulation. Our study suggests that strict application of anticoagulation therapy for thrombophilia of pregnancy is associated with an improved pregnancy outcome. The study was registered in the Australian and New Zealand Clinical Trials Registry under ACTRN12612001094864.</description><subject>Anticoagulants</subject><subject>Clinical Study</subject><subject>Health risk assessment</subject><subject>Mortality</subject><subject>Mutation</subject><subject>Womens health</subject><issn>2090-4436</issn><issn>2090-4444</issn><issn>2090-4444</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kd1rFTEQxYMotrR98l0Cvohy23xscpMXQYofhUqlVnwM2WT2btrd5Jrs9tL_3pRbL9qHzssMc34cZjgIvaLkmFIhThihzQlXVDH5DO0zosmiqfV8N3O5h45KuSa1Gs2WSrxEe6yRmldtH91cwm2ADU4d_majXcEIccI2enwxTy6NUHCI-FcdIt6EqcdXfU5jm9Z9GILFl6HcYD_nEFf4e4ZVtNHdYVsd8I-6GwCfxTKFaZ5CiofoRWeHAkcP_QD9_Pzp6vTr4vziy9npx_OFY0rLBXTOOi5aRqD1TmvfOicZ6EYxopwiXC1FFZSmS8cIAW-511wz6b1glnb8AH3Y-q7ndgTv6kfZDmadw2jznUk2mP-VGHqzSreG60Y0nFWDtw8GOf2eoUxmDMXBMNgIaS6GCsqEkGRJKvrmEXqd5hzre5WSNRhGJK3U-y3lciolQ7c7hhJzn6O5z9Fsc6z063_v37F_U6vAuy3Qh-jtJjzp9gcMMaXB</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Khalafallah, Alhossain A.</creator><creator>Ibraheem, Abdul-Rauf O.</creator><creator>Teo, Qiong Yue</creator><creator>AlBarzan, Abdul-Majeed</creator><creator>Parameswaran, Ramanathan</creator><creator>Hooper, Emily</creator><creator>Pavlov, Toly</creator><creator>Dennis, Amanda E.</creator><creator>Hannan, Terry</creator><general>Hindawi Publishing Corporation</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0097-5241</orcidid><orcidid>https://orcid.org/0000-0002-1580-3135</orcidid></search><sort><creationdate>2014</creationdate><title>Review of Management and Outcomes in Women with Thrombophilia Risk during Pregnancy at a Single Institution</title><author>Khalafallah, Alhossain A. ; Ibraheem, Abdul-Rauf O. ; Teo, Qiong Yue ; AlBarzan, Abdul-Majeed ; Parameswaran, Ramanathan ; Hooper, Emily ; Pavlov, Toly ; Dennis, Amanda E. ; Hannan, Terry</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2896-efcac35b20ebdc99dbcc62e948208c803875bdc8917c200eda3d93926dd52a1f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Anticoagulants</topic><topic>Clinical Study</topic><topic>Health risk assessment</topic><topic>Mortality</topic><topic>Mutation</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khalafallah, Alhossain A.</creatorcontrib><creatorcontrib>Ibraheem, Abdul-Rauf O.</creatorcontrib><creatorcontrib>Teo, Qiong Yue</creatorcontrib><creatorcontrib>AlBarzan, Abdul-Majeed</creatorcontrib><creatorcontrib>Parameswaran, Ramanathan</creatorcontrib><creatorcontrib>Hooper, Emily</creatorcontrib><creatorcontrib>Pavlov, Toly</creatorcontrib><creatorcontrib>Dennis, Amanda E.</creatorcontrib><creatorcontrib>Hannan, Terry</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ISRN obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khalafallah, Alhossain A.</au><au>Ibraheem, Abdul-Rauf O.</au><au>Teo, Qiong Yue</au><au>AlBarzan, Abdul-Majeed</au><au>Parameswaran, Ramanathan</au><au>Hooper, Emily</au><au>Pavlov, Toly</au><au>Dennis, Amanda E.</au><au>Hannan, Terry</au><au>Pacora, P.</au><au>Kühnert, M.</au><au>Palomba, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review of Management and Outcomes in Women with Thrombophilia Risk during Pregnancy at a Single Institution</atitle><jtitle>ISRN obstetrics and gynecology</jtitle><addtitle>ISRN Obstet Gynecol</addtitle><date>2014</date><risdate>2014</risdate><volume>2014</volume><spage>381826</spage><epage>6</epage><pages>381826-6</pages><issn>2090-4436</issn><issn>2090-4444</issn><eissn>2090-4444</eissn><abstract>Pregnancy is a hypercoagulable state associated with an increased risk of venous thromboembolic disease (VTE). We retrospectively studied 38 Caucasian pregnant women with thrombophilia risk and compared their obstetric outcomes with a matched cohort without known thrombophilia risk during the period between January 2007 and December 2010. There were (2) cases with factor V Leiden, (6) prothrombin gene mutation, (1) antithrombin III deficiency, (2) protein C deficiency, (3) protein S deficiency, (10) MTHFR mutation, (7) anti-cardiolipin antibodies, and (1) lupus anticoagulant. Patients without thrombophilia who presented with recurrent unprovoked VTE were considered as high risk (6 cases). Most patients received anticoagulation (34/38) with aspirin only (6), enoxaparin (27), and warfarin (1). Twenty-six out of thirty-eight pregnant women (68.4%) with an increased risk of thrombophilia experienced one or more obstetric complications defined as hypertension, preeclampsia, placenta abruptio, VTE, and oligohydramnios, compared with 15 out of 40 (37.5%) pregnant women in the control group (OR 3.6; 95% CI 1.42, 9.21, P&lt;0.001). The incidence of obstetric complications was significantly higher in the thrombophilia group compared to the controls. However, these complications were the lowest among patients who received full-dose anticoagulation. Our study suggests that strict application of anticoagulation therapy for thrombophilia of pregnancy is associated with an improved pregnancy outcome. The study was registered in the Australian and New Zealand Clinical Trials Registry under ACTRN12612001094864.</abstract><cop>United States</cop><pub>Hindawi Publishing Corporation</pub><pmid>24693443</pmid><doi>10.1155/2014/381826</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0097-5241</orcidid><orcidid>https://orcid.org/0000-0002-1580-3135</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2090-4436
ispartof ISRN obstetrics and gynecology, 2014, Vol.2014, p.381826-6
issn 2090-4436
2090-4444
2090-4444
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3945432
source PubMed Central(OpenAccess)
subjects Anticoagulants
Clinical Study
Health risk assessment
Mortality
Mutation
Womens health
title Review of Management and Outcomes in Women with Thrombophilia Risk during Pregnancy at a Single Institution
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T05%3A55%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20of%20Management%20and%20Outcomes%20in%20Women%20with%20Thrombophilia%20Risk%20during%20Pregnancy%20at%20a%20Single%20Institution&rft.jtitle=ISRN%20obstetrics%20and%20gynecology&rft.au=Khalafallah,%20Alhossain%20A.&rft.date=2014&rft.volume=2014&rft.spage=381826&rft.epage=6&rft.pages=381826-6&rft.issn=2090-4436&rft.eissn=2090-4444&rft_id=info:doi/10.1155/2014/381826&rft_dat=%3Cproquest_pubme%3E1512556070%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2896-efcac35b20ebdc99dbcc62e948208c803875bdc8917c200eda3d93926dd52a1f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1563812061&rft_id=info:pmid/24693443&rfr_iscdi=true